NCT02294461 2025-10-24
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Astellas Pharma Inc
Phase 3 Completed
Astellas Pharma Inc
NYU Langone Health
H. Lee Moffitt Cancer Center and Research Institute